The Swiss market has shown promising performance, up 1.0% over the last week and 8.6% over the past 12 months, with earnings forecasted to grow by 12% annually. In this favorable environment, identifying high-growth tech stocks can be particularly rewarding for investors seeking robust opportunities in Switzerland’s dynamic tech sector.
Top 10 High Growth Tech Companies In Switzerland
| Name | Revenue Growth | Earnings Growth | Growth Rating |
|---|---|---|---|
| LEM Holding | 9.25% | 18.37% | ★★★★☆☆ |
| Santhera Pharmaceuticals Holding | 22.30% | 32.48% | ★★★★★★ |
| Temenos | 7.59% | 14.32% | ★★★★☆☆ |
| SoftwareONE Holding | 8.57% | 41.79% | ★★★★★☆ |
| Comet Holding | 19.03% | 48.25% | ★★★★★☆ |
| Cicor Technologies | 7.10% | 27.73% | ★★★★☆☆ |
| Basilea Pharmaceutica | 9.88% | 36.82% | ★★★★★☆ |
| Kudelski | 9.93% | 120.15% | ★★★★☆☆ |
| MCH Group | 5.18% | 83.82% | ★★★★☆☆ |
| Sensirion Holding | 13.86% | 102.24% | ★★★★★☆ |
Here’s a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Basilea Pharmaceutica AG is a commercial-stage biopharmaceutical company specializing in developing products for oncology and anti-infective therapies, with a market cap of CHF541.81 million.
Operations: The company focuses on the discovery, development, and commercialization of innovative pharmaceutical products in oncology and anti-infective therapies. It generated CHF149.02 million from these activities.
Basilea Pharmaceutica’s revenue for H1 2024 was CHF 76.29 million, a decrease from CHF 84.9 million the previous year, while net income dropped to CHF 20.74 million from CHF 31.8 million. Despite this, the company is expected to see annual earnings growth of 36.82% and revenue growth of 9.9%, outpacing the Swiss market’s average of 4.4%. Significant R&D investments have been made, with expenditures constituting a notable portion of their budget, driving innovation in their biotech segment and potentially enhancing future profitability.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: LEM Holding SA, along with its subsidiaries, offers solutions for measuring electrical parameters across various regions including China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America and has a market cap of CHF1.41 billion.
Operations: LEM Holding SA specializes in providing solutions for measuring electrical parameters globally. The company’s revenue streams are diversified across multiple regions, including China, Japan, South Korea, India, Southeast Asia, Europe, the Middle East, Africa, NAFTA and Latin America.
LEM Holding’s recent earnings report shows a challenging year, with Q1 sales dropping to CHF 80.96 million from CHF 112.34 million and net income falling to CHF 4.78 million from CHF 20.54 million YoY. Despite this, the company has forecasted annual revenue growth of 9.2% and profit growth of 18.4%, outpacing the Swiss market averages of 4.4% and 11.9%, respectively, indicating strong future potential in the tech sector driven by robust R&D investments.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Sensirion Holding AG, with a market cap of CHF1.09 billion, develops, produces, sells, and services sensor systems, modules, and components globally through its subsidiaries.
Operations: Sensirion Holding AG generates revenue primarily from the sale of sensor systems, modules, and components, amounting to CHF237.91 million. The company operates on a global scale through its subsidiaries.
Sensirion Holding, a Swiss tech firm specializing in sensor solutions, has demonstrated robust revenue growth with a forecasted annual increase of 13.9%, outpacing the Swiss market average of 4.4%. Despite reporting a net loss of CHF 36.01 million for H1 2024, compared to a net income of CHF 1.43 million the previous year, the company’s R&D expenditure underscores its commitment to innovation. Sensirion’s earnings are projected to grow by an impressive 102.24% per year, driven by strong R&D investments and strategic industry positioning.
Taking Advantage
Looking For Alternative Opportunities?
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com